|
Re: Resverlogix Announces Annual and Special Meeting of Shareholders
|
6
|
Resverlogix Corp.
|
Oct 07, 2016 11:05AM
|
|
Re: 50% Discount to China deal ...
|
6
|
Resverlogix Corp.
|
Mar 22, 2016 11:29AM
|
|
Re: New Frontiers for both RVX/Zenith
|
6
|
Resverlogix Corp.
|
Apr 18, 2017 03:56PM
|
|
New article on Apabetalone
|
6
|
Resverlogix Corp.
|
Oct 16, 2017 10:30AM
|
|
From abstract 6 days ago: BRD inhibitors are promising candidates to prevent COVID-19 mediated cardiac damage
|
6
|
Resverlogix Corp.
|
Oct 21, 2020 01:59PM
|
|
Question for the board
|
6
|
Resverlogix Corp.
|
Feb 16, 2016 09:38AM
|
|
Re: Quote from a January 19, 2021 review
|
6
|
Resverlogix Corp.
|
Jan 21, 2021 03:46PM
|
|
BET bromodomain suppression inhibits vascular inflammation by blocking NF-κB and
|
6
|
Resverlogix Corp.
|
Oct 27, 2016 04:32PM
|
|
Re: Enrollment
|
6
|
Resverlogix Corp.
|
Aug 22, 2016 02:52PM
|
|
Pharmacological targeting of BET proteins inhibits renal fibroblast activation
|
7
|
Resverlogix Corp.
|
Oct 27, 2016 04:47PM
|
|
New patent application (filed January 18, 2017; published May 4, 2017)
|
7
|
Resverlogix Corp.
|
May 08, 2017 11:32AM
|
|
Re: Back to the FDA
|
7
|
Resverlogix Corp.
|
Oct 04, 2019 11:37AM
|
|
Re: 25% Pop in SP .... Now $1.12
|
7
|
Resverlogix Corp.
|
Mar 15, 2021 10:46AM
|
|
New patent (January)
|
7
|
Resverlogix Corp.
|
Feb 24, 2016 06:07PM
|
|
Re: Beating the dead horse
|
7
|
Resverlogix Corp.
|
Nov 12, 2017 01:49PM
|
|
Re: Microcap bought in CVR deal - stock is up 700%
|
7
|
Resverlogix Corp.
|
Sep 20, 2016 04:59PM
|
|
Re: HL
|
7
|
Resverlogix Corp.
|
Nov 17, 2017 03:55PM
|
|
Re: Peer Reviewed.....A question for the board
|
7
|
Resverlogix Corp.
|
Jan 24, 2016 05:26AM
|
|
Re: Questions for Q1 webcast
|
8
|
Resverlogix Corp.
|
Mar 18, 2016 06:13PM
|
|
Re: Our own BKC on the webcast
|
8
|
Resverlogix Corp.
|
Feb 04, 2021 12:49PM
|
